Acoticyt 150mg Injection
Marketer
Accord Pharmaceuticals
Salt Composition
Carboplatin (150mg)
Overview Acoticyt 150mg Injection
Oncasin 150mg Injection treats ovarian and small cell lung cancers by inhibiting or reducing cancerous cell proliferation. Administered intravenously under medical supervision, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to the prescribed regimen is crucial, as improper usage or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only as directed by your doctor. Common side effects include nausea, vomiting, tiredness, and elevated liver enzymes. A reduction in blood cell counts (red and white) may increase infection or bleeding risks; report fever, sore throat, chills, unusual bleeding/bruising, or dark urine immediately. Regular blood tests monitoring blood cell counts, heart function, liver health, and uric acid levels are necessary. Report any allergic reactions like skin rash, itching, or breathing difficulties. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding. Reliable contraception for both partners is essential throughout treatment to prevent conception.
Primary Ingredients of Acoticyt 150mg Injection
There is no text provided to rephrase.
Uses of Acoticyt 150mg Injection
Cancers of the ovary and lung (small cell type)
Major Benefits of Acoticyt 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Acoticyt 150mg Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Acoticyt 150mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Acoticyt 150mg Injection works:
Oncoticyt 150mg injection is a chemotherapeutic agent. Its mechanism of action involves disrupting the genetic structure (DNA and RNA) within cancerous cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Acoticyt 150mg Injection may pose safety risks; therefore, physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Acoticyt 150mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Acoticyt 150mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Acoticyt 150mg Injection might induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCAUTION
Exercise caution when administering Acoticyt 150mg Injection to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before use. Acoticyt 150mg Injection is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverSAFE IF PRESCRIBED
The use of Acoticyt 150mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Acoticyt 150mg Injection :
Should you forget a scheduled dose of the Acoticyt 150mg Injection, seek advice from your physician.
Facts to Know About Acoticyt 150mg Injection
| Label | Value |
|---|---|
| Chemical Category | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Platinum-based Anticancer Agents |
3,018 People bought this recently